Controversies Challenges Consensus
}
FacebookYouTubeLinkedInX

CX 2024: Get a ringside seat for the big BASIL-3 data reveal

2024-03-14T11:40:59+00:00

No more freestyling, reset your endovascular CLTI practice with new Level 1 evidence

Andrew Bradbury (Birmingham, UK) and the BASIL-3 team of triallists will be presenting, for the very first time, the results of this long-awaited, only fully publicly funded randomised controlled trial (RCT) at CX 2024 (23–25 April, London, UK).

CX 2024: Get a ringside seat for the big BASIL-3 data reveal2024-03-14T11:40:59+00:00

CX 2023: Andrew Bradbury discusses BASIL-2 trial

2023-03-01T12:20:34+00:00

“I am really looking forward to seeing everyone at CX 2023 and it is going to be a great meeting. It is a pleasure and a privilege for us to be part of it and have the opportunity to present our trial data for the first time.”

Data and discussion on revascularisation treatment […]

CX 2023: Andrew Bradbury discusses BASIL-2 trial2023-03-01T12:20:34+00:00

Endovascular repair matches open surgery for treatment of men with complex but low-risk aortoiliac disease using self-expanding covered stents

2019-04-18T17:16:33+01:00

Michele Antonello

Endovascular repair shortens hospital stay and has comparable outcomes to open surgery when balloon-expandable covered stents are used to treat low-risk male patients with complex aortoiliac lesions, new data show. Michele Antonello (Padua, Italy), described some of the study’s key results during a presentation at […]

Endovascular repair matches open surgery for treatment of men with complex but low-risk aortoiliac disease using self-expanding covered stents2019-04-18T17:16:33+01:00
Go to Top